Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Learn how to plan for success using zero based budgeting to achieve your financial goals. Start your journey to success today.
19,670 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Major cryptocurrencies hold support as regulatory and macro headlines shape momentum. The crypto price prediction tod...
As 2026 AI demand shifts, investors weigh TSMC and AMD on who can sustain capacity, pricing power, and growth. This p...
As 2026 unfolds, a significant portion of the U.S. arsenal remains built on aging yet upgraded weapons that continue ...
Citi analysts say Netflix is better positioned to lift pricing now that licensing and regulatory overhangs have eased...
Rocket Lab is tightening revenue visibility with a growing backlog and stronger margins entering 2026. Analysts eye h...
Bitcoin surges in early trading after news that Iran postponed strikes. The move highlights how geopolitical headline...
Two industry giants report divergent strategies as AI demand strengthens the chip market. AVGO and TSMC post strong q...
Apple abandons the stalemate of building bigger AI models. In a bold pivot, the company opens iOS 27 to rival assista...
A closer look at how Lawrence Calcano built iCapital into a leading wealth-tech platform for alternatives. Learn the ...
When markets hit new highs, Berkshire Hathaway's leaders offer a different playbook. Learn how Warren Buffett's Greg ...
A new Gartner study shows that cutting jobs after piloting AI isn’t reliably boosting returns for many large firms. T...